BridgeBio Pharma, Inc. (BBIO) › Shares OutstandingBridgeBio Pharma, Inc. (BBIO) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2018: 92.06M2019: 123.66M2020: 122.85M2021: 147.34M2022: 150.63M2023: 175.08M2024: 190.04M2025: 194.77M194.77M2018Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY2025194.77M+2.5%2024190.04M+8.5%2023175.08M+16.2%2022150.63M+2.2%2021147.34M+19.9%2020122.85M-0.7%2019123.66M+34.3%201892.06M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share